EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Tanshinone IIA preconditioning enhances the therapeutic efficacy of mesenchymal stem cells in Alzheimer’s disease

Ying Ge, Li Zhang, Xiaobo Huang, Juan Huang, Jingjing Wu, Nanqu Huang, Yong Luo

Frontiers in Cell and Developmental Biology · 16.11.2026 · 14

DOI: 10.3389/fcell.2026.1990844 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cell and Developmental Biology, online erschienen am 16.11.2026. Verfasst von Ying Ge und 6 weiteren Autor:innen. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Mesenchymal stem cells (MSCs) have the potential to treat Alzheimer’s disease (AD), but their therapeutic efficacy is limited by apoptosis and other complications during in vitro culture. Tanshinone IIA (Tan IIA), a major lipophilic diterpenoid quinone derived from the traditional Chinese medicine Salvia miltiorrhiza , exhibits antioxidant and anti-inflammatory activities and has been reported to enhance MSC functionality.

Objective

This study aimed to investigate whether Tan IIA preconditioning optimizes MSC function to enhance therapeutic efficacy in AD models, and to elucidate the underlying molecular mechanisms.

Methods

Mouse bone marrow-derived MSCs were preconditioned with 12 μM Tan IIA for 48 h (termed TIIA-MSCs). In vitro assessments included cell proliferation (CCK-8), apoptosis, stemness marker expression, and transcriptomic analysis. TIIA-MSCs or unmodified MSCs (5 × 10 5 cells) were transplanted into 6- to 7-month-old 3 × Tg-AD mice via tail vein injection. Cognitive function was evaluated using the Y-maze, novel object recognition, and Morris water maze tests. Additionally, hippocampal neuronal damage, synaptic ultrastructure, Aβ42 levels, and apoptosis-related protein expression were examined via histology, immunofluorescence, transmission electron microscopy, and Western blotting.

Results

Tan IIA preconditioning significantly promoted MSC proliferation, reduced apoptosis, maintained stemness (Nanog/Oct4), and activated the PI3K/AKT signaling pathway. In the 3 × Tg-AD mouse model, TIIA-MSC transplantation more effectively ameliorated learning and memory deficits, attenuated hippocampal neuronal loss, protected synaptic ultrastructure, and upregulated PSD-95 expression compared with unmodified MSCs. Mechanistically, TIIA-MSCs reduced Aβ42 levels, elevated the Bcl-2/Bax ratio, reduced total cytochrome c levels, and inhibited subsequent Caspase-3/PARP pathway activation in the brain.

Conclusion

Tan IIA preconditioning optimizes MSC functions associated with PI3K/AKT activation and enhances their neuroprotective efficacy against AD-related apoptosis.

Zitieren

APA

Ge, Y., Zhang, L., Huang, X., Huang, J., Wu, J., Huang, N., & Luo, Y. (2026). Tanshinone IIA preconditioning enhances the therapeutic efficacy of mesenchymal stem cells in Alzheimer’s disease. Frontiers in Cell and Developmental Biology, 14. https://doi.org/10.3389/fcell.2026.1990844

Vancouver

Ge Y, Zhang L, Huang X, Huang J, Wu J, Huang N, et al. Tanshinone IIA preconditioning enhances the therapeutic efficacy of mesenchymal stem cells in Alzheimer’s disease. Frontiers in Cell and Developmental Biology. 2026;14. doi:10.3389/fcell.2026.1990844

BibTeX
@article{Ge2026,
  author = {Ge, Ying and Zhang, Li and Huang, Xiaobo and Huang, Juan and Wu, Jingjing and Huang, Nanqu and Luo, Yong},
  title = {Tanshinone IIA preconditioning enhances the therapeutic efficacy of mesenchymal stem cells in Alzheimer’s disease},
  journal = {Frontiers in Cell and Developmental Biology},
  year = {2026},
  volume = {14},
  doi = {10.3389/fcell.2026.1990844}
}
Kostenlos starten →